How does the genomic naive public perceive whole genomic testing for health purposes? A scoping review
- Author(s)
- Sherburn, IA; Finlay, K; Best, S;
- Journal Title
- European Journal of Human Genetics
- Publication Type
- Review
- Abstract
- The benefits of genomic testing are primarily reported in rare disease, cancer diagnosis and disease management. However, as research into its application in common, more complex conditions grows, as well as the increased prevalence of carrier screening programs, the genomic naive public is more likely to be offered testing in future. To promote social acceptability and ethical application of this technology, it is essential that public perceptions of genomics are considered. Previous studies, however, have primarily focussed on the views of those with genetic conditions or those undergoing genetic testing. The aim of this scoping review is to investigate the genomic naive public's perceptions of clinical genomics and clinical genomic testing. Embase, MEDLINE and PubMed databases were searched, with a total of 3460 articles identified. Data analysis was organised according to the nonadoption, abandonment, scale-up, spread, and sustainability (NASSS) framework. Sixteen full-text articles were included in the final analysis. Most of the studies used questionnaires to determine attitudes of the public toward clinical genomics (n = 12). Public perceptions were found to underpin technology (Domain 2), value proposition (Domain 3), the adopter system (Domain 4) and the wider context (Domain 6) of the NASSS framework, highlighting its importance when considering implementation of an innovative technology such as genomic testing. Our study shows public perceptions are diverse, and highlights the need for more studies on the views of underrepresented groups and the impact of cultural contexts on perceptions.
- Publisher
- Springer Nature
- Keywords
- Humans; *Genomics; *Disease Management; Genetic Testing; Surveys and Questionnaires; Medline
- Department(s)
- Health Services Research
- PubMed ID
- 36257982
- Publisher's Version
- https://doi.org/10.1038/s41431-022-01208-5
- Open Access at Publisher's Site
https://doi.org/10.1038/s41431-022-01208-5- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-06-13 07:55:30
Last Modified: 2023-06-13 07:56:08